logo
  1. Home
  2. Stocks
  3. Ipca Laboratories

Ipca Laboratories Share Price

Mid Cap | Pharmaceuticals and health care | NSE: IPCALAB | BSE: 524494

₹1,399.25 image-98.35 (-6.57 %)

Last Updated: 04 Apr 2025 03:59 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 1,481.00

High (₹) 1,491.75

Low (₹) 1,358.50

Prev. Close (₹) 1,497.60

Volume 9,45,827

VWAP (₹) 1,355.24

ROCE (%) 12.44

Industry P/E 44.73

TTM P/E 48.67

P/B Ratio 4.59

Market Cap (₹) Cr.35,499.56

Dividend Yield (%)0.29

EPS (₹) 21.57

ROE7.08%

Sales Growth (%) 23.39

Profit Growth (%)7.58

Day Range

1,491.751,491.75

L
H

52 Week Range

1,060.951,757.65

L
H

Historical Returns

Returns (6M)

-5.87 %

Returns (1Y)

6.44 %

Returns (3Y)

36.87 %

Returns (5Y)

83.37 %

Returns (6M)

-5.87 %

Returns (1Y)

6.44 %

Returns (3Y)

36.87 %

Returns (5Y)

83.37 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (16.09%) TTM EPS Growth
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Company with 16.09% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 60.98

MFI 32.86

ATR 60.58

Commodity Channel Index -206.89

ROC125 -0.89

ROC21 -6.83

Williams %R -90.23

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current1,374.601,393.851,412.651,355.801,336.551,317.751,298.50
Week Ago1,496.261,547.581,587.161,456.681,405.361,365.781,314.46
Month Ago1,426.341,469.921,495.941,400.321,356.741,330.721,287.14

EMA & SMA
info_icon

1399.25

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 1418.34

9 Day 1445.53

10 Day 1444.62

12 Day 1438.05

14 Day 1442.42

20 Day 1447.32

26 Day 1454.59

50 Day 1529.71

100 Day 1549.44

200 Day 1424.77

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell14 Nov, 2022₹867.551,58,841NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy14 Nov, 2022₹867.551,58,841NSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell03 Nov, 2022₹927.151,58,842NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy03 Nov, 2022₹927.151,58,842NSE
ISHARES INDIA SC MAURITIUS COMPANYblockSell03 Oct, 2022₹915.0025,067NSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell03 Oct, 2022₹915.001,70,778NSE
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy03 Oct, 2022₹915.0025,067NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy03 Oct, 2022₹915.001,70,778NSE
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.bulkBuy30 Nov, 2021₹2,103.5225,46,497NSE
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.bulkSell27 Nov, 2020₹2,158.7020,15,056NSE
GOLDMAN SACHS INVESTMENTS MAURITIUS I LTDbulkSell27 Nov, 2020₹2,173.456,75,065NSE
BNP PARIBAS ARBITRAGEbulkSell27 Nov, 2020₹2,154.2713,11,732NSE
GOLDMAN SACHS INVESTMENTS MAURITIUS I LTDbulkBuy27 Nov, 2020₹2,173.1069,473NSE
BNP PARIBAS ARBITRAGEbulkBuy27 Nov, 2020₹2,162.44194NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
19 Dec, 2024Mrs. Usha M. ChandurkarDisposal₹1,499.2540,00,000NSE
12 Mar, 2024Paschim Chemicals Pvt. Ltd.Acquisition₹1,200.9735,000NSE
20 Nov, 2023Mr. Ajit Kumar JainDisposal₹1,081.8520,000NSE
19 Sept, 2022Mr. E. J. Babu Former Designated EmployeeDisposal₹874.382,000NSE
04 Aug, 2022Mrs. Usha ChandurkarAcquisition₹40,00,000NSE
01 Aug, 2022Mrs. Usha ChandurkarAcquisition₹3,02,000NSE
21 Mar, 2022Mr. A. K. JainDisposal₹1,026.8220,000NSE
26 Aug, 2021Kavita SehwaniDisposal₹2,441.16450NSE
23 Aug, 2021Pabitra Kumar BhattacharyyaDisposal₹2,510.004,000NSE
19 Aug, 2021Ajit Kumar JainDisposal₹2,421.9010,000NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
24 Oct, 2024Rs.2.0000 per share(200%)Interim Dividend (Revised)25 Nov, 202425 Nov, 2024
29 May, 2024Rs.2.0000 per share(200%)Final Dividend06 Aug, 202401 Jan, 1970
26 Oct, 2023Rs.2.0000 per share(200%)Interim Dividend (Revised)22 Nov, 202322 Nov, 2023
13 Nov, 2021Stock split from Rs. 2/- to Re. 1/-.10 Jan, 202211 Jan, 2022

Announcements

DateSourceDetail
02 Apr, 2025NSE IndiaKaygee Investments Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
28 Mar, 2025NSE IndiaIPCA LABORATORIES LIMITED has informed the Exchange regarding Sale or disposal of unit(s)/division(s)/subsidiary
28 Mar, 2025NSE IndiaIPCA LABORATORIES LIMITED has informed the Exchange regarding Acquisition
28 Mar, 2025NSE IndiaIPCA Laboratories Limited has informed the Exchange about General Updates - Slump Sale of Manufacturing Unit and Acquisition
28 Mar, 2025BSE IndiaSlump Sale of Manufacturing Unit and Acquisition
28 Mar, 2025BSE IndiaAnnouncement under Reg 30 (LODR) - Acquisition
28 Mar, 2025NSE IndiaIPCA Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on March 28, 2025.
28 Mar, 2025BSE IndiaOutcome of Board Meeting - 28.03.2025
26 Mar, 2025NSE IndiaIPCA LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window
26 Mar, 2025NSE IndiaIPCA Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--28 Jan, 202513 Feb, 2025
Quarterly Results & Interim Dividend--25 Oct, 202414 Nov, 2024
Others--25 Sept, 202430 Sept, 2024
Quarterly Results--25 Jul, 202413 Aug, 2024
Audited Results & Final Dividend--08 May, 202429 May, 2024
Quarterly Results--24 Jan, 202414 Feb, 2024
Quarterly Results & Interim Dividend--26 Oct, 202310 Nov, 2023
Quarterly Results--24 Jul, 202310 Aug, 2023
Audited Results--15 May, 202329 May, 2023
Quarterly Results--23 Jan, 202314 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameSept, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group46.3%46.29%46.29%46.29%46.29%
Foreign Institutions +10.83%10.27%10.46%12.34%18.22%
Domestic Institutions +34.22%34.51%34.03%30.02%24.22%
Government0%0%0%0%0%
Public8.65%8.93%9.22%11.35%11.27%
Others0%0%0%0%0%

About Ipca Laboratories

Ipca Laboratories is a Public Limited Listed company incorporated on 19/10/1949 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1949PLC007837 and registration number is 007837. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 6166.46 Cr. and Equity Capital is Rs. 25.37 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1949

Managing Director

Mr. Ajit Kumar Jain

NSE Symbol

IPCALAB

Ipca Laboratories Management

NameDesignation
Mr. Premchand GodhaExecutive Chairman
Mr. Ajit Kumar JainManaging Director
Mr. Pranay GodhaManaging Director
Mr. Prashant GodhaExecutive Director
Dr.(Mrs.) Manisha PremnathIndependent Director
Mr. Kamal Kishore SethIndependent Director
Dr. Narendra MairpadyIndependent Director
Dr.(Ms.) Swati PatankarIndependent Director
Mr. Vivek ShiralkarIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)		₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)		₹1,910.100 - ₹3,050.000

FAQs on Ipca Laboratories

What is the share price of Ipca Laboratories?

The share price of Ipca Laboratories on 04 Apr, 2025 is ₹ 1,399.25.

What is 52W high and 52W low share price of Ipca Laboratories?

The highest and lowest 52W share prices of Ipca Laboratories are ₹ 1757.650 and ₹ 1060.950

What is the market cap of Ipca Laboratories?

The market capitalization of Ipca Laboratories as of 04 Apr, 2025 is ₹ 35,499.56 Crores

What is the P/E ratio of Ipca Laboratories?

The current P/E ratio of Ipca Laboratories as of 04 Apr, 2025 is 44.73

What is the PB ratio of Ipca Laboratories?

The PB ratio of Ipca Laboratories as of 04 Apr, 2025 is 4.59

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited